Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro

International Journal of Cancer

Volumn 80, Issue 5, 1999, Pages 764-772

  Tonn, Joerg Christian ^a   Kerkau, Siglinde ^a   Hanke, Anne ^a   Bouterfa, Hakim ^a   Mueller, Justus G ^a   Wagner, Sven ^a   Vince, Giles Hamilton ^a   Roosen, Klaus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ARTICLE; CANCER INVASION; CELL PROLIFERATION; CYTOTOXICITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BRAIN; CELL AGGREGATION; CELL DIVISION; COLLAGENASES; ENZYME INHIBITORS; FETUS; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEURONS; PHENYLALANINE; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOPHENES; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032958428     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990301)80:5<764::AID-IJC22>3.0.CO;2-J     Document Type: Article

References (21)

1. BECKETT, R.P., DAVIDSON, A.H., DRUMMOND, A.H., HUXLEY, P. and WHITTAKER, M., Recent advances in matrix metalloproteinase inhibitor research. Drug Discovery Today, 1, 16-26 (1996).
2. BIRKEDAL-HANSEN, H., Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol., 7, 728-735 (1995).
3. BRAMHALL, S.R., The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int. J. Pancreatol., 21, 1-12 (1997).
4. CHIRIVI, R.G.S., GAROFALO, A., CRIMMIN, M.J., BAWDEN, L.J., STOPPACCIARO, A., BROWN, P.D. and GIAVAZZI, R., Inhibition of the metastatic spread and growth of B16-B6L murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer, 58, 460-464 (1994).
5. DAVIES, B., BROWN, P.D., EAST, M., CRIMMIN, M.J. and BALKWILL, F.R., A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival in mice bearing human ovarian-tumor xenografts. Cancer Res., 53, 2087-2091 (1993).
6. ECCLES, S., BOX, G.M., COURT, W.J., BONE, E.A., THOMAS, W. and BROWN, P.D., Control of lymphatic and hematogeneous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res., 56, 2815-2822 (1996).
7. ENNIS, B.W. and MATRISIAN, L.M., Matrix degrading metalloproteinases. J. Neurooncol., 18, 105-109 (1994).
8. GOMEZ, D.E., ALONSO, D.F., YOSHIJI, H. and THORGEIRSSON, U.P., Tissue inhibitors of metalloproteinases: structure, regulations and biological functions. Europ. J. Cell Biol., 74, 111-122 (1997).
9. NAKAGAWA, T., KUBOTA, T., KABUTO, M., SATO, K., KAWANO, H., HAYAKAWA, T. and OKADA, Y., Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg., 81, 69-77 (1994).
10. ROMANIC, A.M. and MADRI, J.A., Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol., 4, 145-156 (1994).
11. ROOPRAI, H.K. and MCCORMICK, D., Proteases and their inhibitors in human brain tumors: a review. Anticancer Res., 17, 4151-4162 (1997).
12. ROSSI, M., ROOPRAI, H.K., MAIDMENT, S.L., RUCKLIDGE, G.J. and PILKINGTON, G.J., The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain-tumor cells. Anticancer Res., 16, 121-128 (1996).
13. SLEDGE, G.W., JR., QULALI, M., GOULET, R., BONE, E.A. and FIFE, R., Effect of matrix-metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J. nat. Cancer Inst., 87, 1546-1550 (1995).
14. TONN, J.-C., HAUGLAND, H.K., SARASTE, J., ROOSEN, K. and LAERUM, O.D., Differential effects of vincristine and phenytoin on the proliferation, migration and invasion of human glioma cell lines. J. Neurosurg., 82, 1035-1043 (1995).
15. UHM, J.H., DOOLEY, N.P., VILLEMURE, J.G. and YONG, V.W., Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can. J. neurol. Sci., 24, 3-15 (1997).
16. VINCE, G.H., WAGNER, S., PIETSCH, T., GOLDBRUNNER, R.H., BOUTERFA, H., ROOSEN, K. and TONN, J.-C., Intratumoral heterogeneous expression of matrix-metalloproteinases in astrocytic tumors. Anticancer Res., 17, 4061 (1997).
17. WAGNER, S., VINCE, G.H., GREIF, M., PIETSCH, T., RIECKMANN, P., ROOSEN, K. and TONN, J.-C., IL-10 mediated enhancement of glioma cell migration/ invasion is not related to MMP-expression. Anticancer Res., 17, 4061 (1997).
18. WATSON, S.A., MORRIS, T.M., ROBINSON, G., CRIMMIN, M.J., BROWN, P.D. and HARDCASTLE, J.D., Inhibition of organ invasion by matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon-carcinoma metastasis models. Cancer Res., 55, 3629-3633 (1995).
19. WOJTOWICZ-PRAGA, S., LOW, J., MARSHALL, J., NESS, E., DICKSON, R., BARTER, J., SALE, M., MCCANN, P., MOORE, J., COLE, A. and HAWKINS, M.J., Phase 1 trial of a novel matrix-metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Invest. New Drugs, 14, 193-202 (1996).
20. WOJTOWICZ-PRAGA, S.M., DICKSON, R.B. and HAWKINS, M.J., Matrix metalloproteinase inhibitors. Invest. New Drugs, 15, 61-75 (1997).
21. ZUBAIR, A.C., ALI, S.A., REES, R.C., GOEPEL, J.R. and GOYNS, M.H., Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice. Cancer Lett., 107, 91-95 (1996).